Osimertinib in First-Line Treatment—is a Comparison Not Proof?
Annals of Translational Medicine - China
doi 10.21037/atm.2017.12.13
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 1, 2018
Authors
Publisher
AME Publishing Company